Vesselplasty for the treatment of osteoporotic vertebral compression fractures with peripheral wall damage: a

Jiguang Chen1, Chongqing Xu2, Jiangming Yu1

  • 1Department of Orthopaedics, Changzheng Hospital, Second Military Medical University, Shanghai, PR China.

Insights

Vesselplasty offers a safer alternative for treating osteoporotic vertebral compression fractures (OVCF), reducing bone cement leakage and improving vertebral height and kyphosis. This technique shows significant clinical value for OVCF with peripheral wall damage.

Area of Science:

  • Orthopedic surgery
  • Spinal interventions
  • Biomaterials in medicine

Background:

  • Vertebroplasty and kyphoplasty are common treatments for osteoporotic vertebral compression fractures (OVCF).
  • These procedures have limitations including bone cement leakage (BCL), incomplete kyphosis correction, and inadequate vertebral height restoration.
  • Vesselplasty has emerged as an alternative to address these shortcomings.

Purpose of the Study:

  • To evaluate the clinical efficacy and application value of vesselplasty for treating OVCF.
  • Specifically assess outcomes in patients with peripheral wall damage.

Main Methods:

  • A retrospective study of 62 patients (70 vertebrae) treated with vesselplasty for OVCF with peripheral wall damage.
  • Data collected included operation time, bone cement volume, complications, visual analog scale (VAS), Oswestry disability index (ODI), vertebral body height, and kyphosis Cobb angle.

Main Results:

  • A low rate of bone cement leakage (4.3%) was observed.
  • Significant improvements in VAS and ODI scores post-procedure (p < 0.05).
  • Significant restoration of vertebral body height and correction of kyphosis (p < 0.05).

Conclusions:

  • Vesselplasty demonstrates a reduced risk of BCL and better bone cement control in OVCF treatment.
  • The procedure effectively relieves pain, restores vertebral height, and corrects kyphosis, particularly in cases with peripheral wall damage.
  • Vesselplasty is a safe and clinically valuable option for OVCF management.
Abstract